Porciani Maria Cristina, Attanasio Monica, Lepri Valentina, Lapini Ilaria, Demarchi Gabriele, Padeletti Luigi, Pepe Guglielmina, Abbate Rosanna, Gensini Gian Franco
Centro di Riferimento Regionale per la Sindrome di Marfan e Malattie Correlate, Clinica Medica e Cardiologia, Università degli Studi, Firenze.
Ital Heart J Suppl. 2004 Aug;5(8):647-52.
Marfan syndrome is an inherited connective tissue disorder with an autosomic dominant transmission. The prevalence is 1:5000-10 000 and the clinical major criteria involve the skeletal and ocular apparatus and the cardiovascular and central nervous system. The main cause of morbidity is represented by the thoracic aortic dissection/aneurysm that is responsible for 80% of the deaths.
We performed a clinical study on 227 patients enrolled at our Clinical and Research Marfan and Related Disorders Center. The aim of this study was to describe the prevalence of cardiovascular manifestation in this cohort of patients.
Aortic dilation was present in 172 patients (75.8%), mitral valve prolapse in 179 (78.9%). Aortic insufficiency was present in 83 patients (36.6%), mitral insufficiency in 165 (72.7%). When analyzed separately, in < 10-year and > 40-year patients aortic dilation was more prevalent than mitral valve prolapse. Three patients presented with interatrial septal defect, 4 aortic bicuspid valve; 23 had a history of ventricular and supraventricular arrhythmias, and in 2 patients an implantable cardioverter device had been implanted. Fifty-seven patients were treated with beta-blockers and 28 had been operated for aortic aneurysmal dilation.
In Marfan syndrome mitral valve prolapse and aortic dilation are the main cardiovascular manifestations, interatrial septal defect and aortic bicuspid valve had the same prevalence than in subjects without Marfan syndrome. These data refer to our first patient evaluation; further studies are needed to evaluate the progression and the natural history of cardiovascular manifestations in Marfan syndrome.
马凡综合征是一种常染色体显性遗传的遗传性结缔组织疾病。患病率为1:5000 - 10000,临床主要标准涉及骨骼和眼部器官以及心血管和中枢神经系统。发病的主要原因是胸主动脉夹层/动脉瘤,其导致了80%的死亡。
我们对在我们的马凡及相关疾病临床与研究中心登记的227例患者进行了一项临床研究。本研究的目的是描述该队列患者心血管表现的患病率。
172例患者(75.8%)存在主动脉扩张,179例(78.9%)存在二尖瓣脱垂。83例患者(36.6%)存在主动脉瓣关闭不全,165例(72.7%)存在二尖瓣关闭不全。单独分析时,在年龄小于10岁和大于40岁的患者中,主动脉扩张比二尖瓣脱垂更常见。3例患者出现房间隔缺损,4例出现主动脉二叶瓣;23例有室性和室上性心律失常病史,2例植入了植入式心脏复律除颤器。57例患者接受了β受体阻滞剂治疗,28例因主动脉瘤扩张接受了手术。
在马凡综合征中,二尖瓣脱垂和主动脉扩张是主要的心血管表现,房间隔缺损和主动脉二叶瓣的患病率与无马凡综合征的受试者相同。这些数据基于我们对首批患者的评估;需要进一步研究来评估马凡综合征心血管表现的进展和自然病史。